Head of Droplet-based Microfluidics Applications - Associate Director

About Us:

Shennon Biotechnologies is developing precision immunotherapies for solid tumors through an integrated technology platform spanning target discovery, ultra-high-throughput microfluidics-driven functional screening, computational binder design and predictive safety assessment. In particular, where conventional discovery tests binders sequentially over months, our functional screening platform TCELERATOR profiles more than 10 million single-cell interactions at once, identifying functional leads in a single experiment. The unified engine is supported by proprietary human tumor datasets and an expanding network of academic and clinical collaborators. We are developing both antibody-based and TCR-based T-cell engagers designed to address surface and intracellular cancer targets. Our initial oncology pipeline includes programs in small cell lung cancer, ovarian cancer and hepatocellular carcinoma. We are based in the dogpatch neighborhood of San Francisco with 6000 sqft of lab space. For more information, visit www.shennonbio.com.

The Role:

Reporting directly to the Chief Technology Officer, the Associate Director of Droplet-based Microfluidics Applications should be an experienced leader with hands-on expertise in droplet-based microfluidic applications (such as droplet-based sequencing and/or droplet-based screening), who can think across biology